Navigation Links
Vermillion Reports Financial Results for the First Quarter 2011
Date:5/10/2011

the Johns Hopkins University School of Medicine to identify biomarkers that improve on the specificity of CA125 for the identification of malignant ovarian tumors.
  • Commenced enrollment of subjects in the PAD intended use study being performed in collaboration with the Colorado Prevention Center. The study remains on track to result in top-line data during the third quarter of 2011.
  • Strengthened our balance sheet by completing an underwritten follow-on public offering of our common stock, resulting in approximately $20.2 million net proceeds to the Company.

  • "We continued to make progress in multiple areas during the first quarter.  We grew OVA1 sales as well as had several presentations highlighting the benefit of OVA1 as an aid for physicians in the assessment of adnexal masses.  On the clinical development front, our PAD and OVA2 programs moved forward and remain on track to generate data later this year.  We also strengthened our balance sheet, which affords us the flexibility to help accelerate our current initiatives as well as opportunistically act on potential new growth drivers," said Gail S. Page, Chair of the Board of Directors and CEO.

    For the second quarter of 2011, we expect 3,200 to 3,500 OVA1 tests to be performed.  This forward guidance takes into consideration numerous factors including the number of days in the quarter, continued limited coverage by the larger payers, and the ability to expand the number of diagnosis codes currently approved by Medicare.

    Total revenues for the first quarter of 2011 were $431,000 compared to $73,000 for the first quarter of 2010.  Revenues for the first quarter of 2011 included $317,000 from product sales of OVA1 and $114,000 of license revenue related to the Company's achievement of certain milestones under the Strategic Alliance Agreement with Quest Diagnostics.  As of March 31, 2011, the Company's cash and short-term investments totaled $40.2
    '/>"/>

    SOURCE Vermillion, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Vermillion Receives Award From the Society of Gynecologic Oncologists
    2. Vermillions Biomarkers Prove Beneficial in Identifying Women With Ovarian Cancer and Detecting Early-Stage Disease
    3. Vermillion and the Ohio State University Report That Novel Diagnostic Test May Help Predict Risk for Relapse of TTP, A Serious Blood Disorder
    4. Vermillion Files 510(k) Application With U.S. Food & Drug Administration for OVA1 Ovarian Tumor Triage Test
    5. Vermillion Renews Strategic Alliance Agreement With Quest Diagnostics, Inc.
    6. Vermillion Presents Critical Data From Its OVA1 Clinical Trial
    7. Vermillion Announces the Reappointment of Officers and Confirmation of Director
    8. Vermillion to Present at Lazard Capital Markets Sixth Annual Healthcare Conference
    9. Vermillion Announces $43.05 Million Private Placement of Common Stock
    10. Vermillion Files Plan of Reorganization
    11. Vermillion Files Amended Plan of Reorganization and Exchanges Debt
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/2/2015)... , Sept. 2, 2015 Research ... addition of the "Medical Device Studies: Clinical ... conference to their offering. This ... are involved in gathering clinical evidence required for ... is required for all medical devices and the ...
    (Date:9/2/2015)... 2, 2015 Research and Markets ( ... PharmaBiotech,s new report "Drug Delivery in Central ... to their offering. Advances ... BBB have opened new avenues and possibilities for ... or transport systems, enzymes, and receptors that control ...
    (Date:9/2/2015)... MARIETTA, Ga. , Sept. 2, 2015  MiMedx ... regenerative medicine company utilizing human amniotic tissue and ... and therapies for the Wound Care, Surgical, Orthopedic, ... healthcare, today corrected the inaccurate statements published by ... release of September 1, 2015. MTF,s ...
    Breaking Medicine Technology:Medical Device Studies: Clinical Evidence Course - London, UK - November 10-11, 2015 2Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies Report 2015-2024 2Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies Report 2015-2024 3MiMedx Corrects A Second Inaccurate MTF Press Release 2MiMedx Corrects A Second Inaccurate MTF Press Release 3
    (Date:9/2/2015)... ... , ... The medical waste management market is expected to reach USD 13.3 ... The global medical waste management market is segmented based on type of waste, services, ... register the highest growth rate in the medical waste management market, by service, during ...
    (Date:9/2/2015)... ... September 02, 2015 , ... A UPMC and University ... international recognition as a premier center for treatment of and research into hereditary ... bleeding and stroke. , Cure HHT, previously known as The HHT Foundation ...
    (Date:9/2/2015)... ... September 02, 2015 , ... Since 2011, DoMyOwnPestControl.com has ... to help support childhood cancer research. On June 17, 2014, the owners ... , which is the fund-raising event DoMyOwnPestControl.com sponsors each year. The very next ...
    (Date:9/2/2015)... ... September 02, 2015 , ... ... is taking action after seeing a significant increase in unlawful tactics used ... division has found many cases of OON ASCs encouraging members to have elective ...
    (Date:9/2/2015)... ... ... A recent survey by Consumer Reports ( http://bit.ly/1h67tL8 ) sheds light on ... consumers. It was reported that 33% are paying an average of $39 more out-of-pocket ... $100 compared to last year. Among the drugs that saw the highest increases were ...
    Breaking Medicine News(10 mins):Health News:Medical Waste Management Market Growing at 5.2% CAGR to 2020 2Health News:Medical Waste Management Market Growing at 5.2% CAGR to 2020 3Health News:Medical Waste Management Market Growing at 5.2% CAGR to 2020 4Health News:Medical Waste Management Market Growing at 5.2% CAGR to 2020 5Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 2Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 3Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 4Health News:DoMyOwnPestControl.com Goes Gold for Childhood Cancer Awareness Month 2Health News:TPA Cracks Down on Forbidden Tactics Used by Out-of-Network Surgical Centers 2Health News:TPA Cracks Down on Forbidden Tactics Used by Out-of-Network Surgical Centers 3Health News:Watertree Health President Responds to Consumer Reports Survey on Rising Prescription Drug Prices 2
    ... , What: Cuts for a Cause , ... and other terminal illnesses affecting children. All proceeds from each hair ... Guests will enjoy complimentary beverages and hors d,oeuvres, provided by Four ... all guests. Hoa Lai, a DJ known for creating fun and ...
    ... debunks the ,something,s wrong with being single, myth , SATURDAY, ... who pass their 40th birthday without ever tying the knot, ... woes than married folks. And, um, isn,t there something wrong ... fast. , A new study looking at psychological measures shows ...
    ... , PALO ALTO, Calif., Dec. 4 Varian Medical ... Directors has set the regular 2010 Annual Meeting of Stockholders for February ... will be held at the Crowne Plaza Cabana Hotel, 4290 El Camino ... be webcast by Thomson Financial and can be accessed at Varian Medical ...
    ... WASHINGTON, Dec. 4 The American Association of Homes and ... that the Community Living and Supportive Services (CLASS) provisions ... provisions are essential for providing support to elders, people with ... to pass a health care reform bill that will make ...
    ... , WASHINGTON, Dec. 4 While ... care costs, Leapfrog,s purchaser members point to 45 hospitals ... care in the nation while attaining the highest levels ... hospitals have been named 2009 Leapfrog Top Hospitals, based ...
    ... Reserve University researchers, from the School of Medicine,s Department ... products of lipid peroxidation and some drugs of abuse, ... by a combination of metabolomics and mass isotopomer analysis. ... action of the drug of abuse gamma-hydroxybutyrate, also known ...
    Cached Medicine News:Health News:Never Married, Over 40, Well-Adjusted 2Health News:Never Married, Over 40, Well-Adjusted 3Health News:Varian Medical Systems Schedules Annual Stockholder Meeting in Palo Alto 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 3Health News:Case Western Reserve researchers' new pathway discovery published as 'Paper of the Week' 2
    Straight shafts with 13 mm crisscross serrated platform with polished finish. Serrated handle....
    Straight shafts with 15 mm long jaws. Serrated handle with polished finish. Crisscross jaws....
    Straight shafts with 3 mm platform. Wide serrated handle with polished finish....
    Straight shafts with 1 x 2 teeth. Flat handle with haoles and polished finish. Delicate teeth. Most popular size or model....
    Medicine Products: